Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Appendicitis-II: Diagnostic Studies and Management

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bedside echocardiography to predict mortality of COVID-19 patients beyond clinical data: Data from the PROVAR-COVID study.

Revista da Sociedade Brasileira de Medicina Tropical·2021

Same author

Necrobiotic xanthogranuloma associated with smoldering multiple myeloma: satisfactory response to cyclophosphamide, dexamethasone, and thalidomide.

Anais brasileiros de dermatologia·2019

Same author

Changes in the Brazilian Annals of Dermatology. Unpostponable initiatives.

Anais brasileiros de dermatologia·2019

Same author

Mucosal vitiligo in angles of the mouth: clinical and fluorescence aspects.

Revista da Associacao Medica Brasileira (1992)·2019

Same author

Thanks and reply from the editors of the ABD to the comments on the correspondence sent to heads of services accredited by SBD.

Anais brasileiros de dermatologia·2018

Search research articles

Related Experiment Video

Updated: Jan 29, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

Scrofuloderma: a diagnostic challenge.

Renan Bernardes de Mello¹, Everton Carlos Siviero do Vale¹, Isabela Guimarães Ribeiro Baeta²

¹Dermatology Service, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte (MG), Brazil.

Anais Brasileiros De Dermatologia

|February 7, 2019

Summary

Cutaneous tuberculosis, a rare skin manifestation of Mycobacterium tuberculosis, presents diverse symptoms that can mimic other skin conditions. This case highlights a delayed diagnosis of scrofuloderma, emphasizing the need for increased awareness and diagnostic vigilance.

More Related Videos

Microfluidic Applications for Disposable Diagnostics

Microfluidic Applications for Disposable Diagnostics

Published on: February 3, 2008

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

Related Experiment Videos

Last Updated: Jan 29, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

Microfluidic Applications for Disposable Diagnostics

Microfluidic Applications for Disposable Diagnostics

Published on: February 3, 2008

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

Area of Science:

Dermatology
Infectious Diseases
Microbiology

Background:

Cutaneous tuberculosis (CTB) is a rare manifestation of extrapulmonary tuberculosis, accounting for 1-2% of all tuberculosis cases.
It is caused by Mycobacterium tuberculosis or closely related mycobacterial species.
CTB exhibits diverse clinical presentations, often mimicking other chronic dermatoses, which can lead to diagnostic challenges.

Observation:

A specific case of scrofuloderma, a form of cutaneous tuberculosis affecting the skin and subcutaneous tissue, is presented.
The patient experienced a significant delay in diagnosis and treatment, with the condition persisting for six years from its initial onset.
The clinical presentation likely mimicked other common dermatological conditions, contributing to the delayed recognition of tuberculosis.

Findings:

The reported case underscores the diagnostic difficulties associated with cutaneous tuberculosis due to its varied clinical appearance.
Delayed diagnosis in CTB can lead to prolonged suffering and potential complications.
Prompt and accurate diagnosis is crucial for effective management and treatment of cutaneous tuberculosis.

Implications:

Increased clinical suspicion and awareness of cutaneous tuberculosis are essential among dermatologists and infectious disease specialists.
The case emphasizes the importance of considering tuberculosis in the differential diagnosis of chronic, non-responsive dermatoses, particularly in endemic areas.
Improved diagnostic strategies and earlier recognition of CTB are needed to prevent disease progression and improve patient outcomes.